Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.

They have to figure out how to distribute the vaccines — and keep their citizens interested in getting their jab — without knowing when supplies will arrive.